This list is based on the watchlists of people on Stock Events who follow MBGPF. It's not an investment recommendation.
This list is an analysis based on recent market events. It's not an investment recommendation.
Moberg Pharma AB (publ), a pharmaceutical company, develops and commercializes medical products primarily in Sweden. It offers MOB-015 for the treatment of nail fungus under the Terclara brand. The company was formerly known as Moberg Derma AB (publ) and changed its name to Moberg Pharma AB (publ) in May 2013. Moberg Pharma AB (publ) was incorporated in 2006 and is based in Bromma, Sweden.
Show more...
FAQ
What is Moberg Pharma AB stock price today?▼
The current price of MBGPF is $1 USD — it has increased by +0% in the past 24 hours. Watch Moberg Pharma AB stock price performance more closely on the chart.
What is Moberg Pharma AB stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Moberg Pharma AB stocks are traded under the ticker MBGPF.
Is Moberg Pharma AB stock price growing?▼
MBGPF stock has risen by +0% compared to the previous week, the month change is a -9.47% fall, over the last year Moberg Pharma AB has showed a +26.1% increase.
What is Moberg Pharma AB market cap?▼
Today Moberg Pharma AB has the market capitalization of 48.71M
When is the next Moberg Pharma AB earnings date?▼
Moberg Pharma AB is going to release the next earnings report on May 12, 2026.
What is Moberg Pharma AB revenue for the last year?▼
Moberg Pharma AB revenue for the last year amounts to 4.13M USD.
What is Moberg Pharma AB net income for the last year?▼
MBGPF net income for the last year is -7.42M USD.
In which sector is Moberg Pharma AB located?▼
Moberg Pharma AB operates in the Professional, Scientific, and Technical Services sector.
When did Moberg Pharma AB complete a stock split?▼
Moberg Pharma AB has not had any recent stock splits.
Where is Moberg Pharma AB headquartered?▼
Moberg Pharma AB is headquartered in Bromma, SE.